Frequency and Risk Factors for Hyperglycemia in Children with Acute Lymphoblastic Leukemia During Induction Chemotherapy
Background: Hyperglycemia is a common side effect and it has long been recognized as a consequence of corticosteroids and L-asparaginase, chemotherapeutic agents key to ALL treatment. This study was done to determine the frequency and identify the risk factors for hyperglycemia in paediatric ALL dur...
Gespeichert in:
| Veröffentlicht in: | Bangladesh journal of child health 2022-11, Vol.45 (3), p.155-161 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 161 |
|---|---|
| container_issue | 3 |
| container_start_page | 155 |
| container_title | Bangladesh journal of child health |
| container_volume | 45 |
| creator | Ahammed, Md Tanvir |
| description | Background: Hyperglycemia is a common side effect and it has long been recognized as a consequence of corticosteroids and L-asparaginase, chemotherapeutic agents key to ALL treatment. This study was done to determine the frequency and identify the risk factors for hyperglycemia in paediatric ALL during induction chemotherapy.
Material & Methods: This prospective observational study was done among 87 newly diagnosed ALL cases of 1-18 years of age. After initial work up patient got induction chemotherapy according to UK ALL 2003 (modified) protocol in BSMMU. Anthropometric measurements and CBC, RBS/ 2 hours after glucose/ FBS and corresponding urine sugar was assessed after 2nd, 4th, 6th and 9th dose of Lasparaginase and after completion of induction. Data were analyzed by SPSS 17.0.
Results: Eight patients (9.75%) of the study cohort developed hyperglycemia. Among ³10 years of age 36.8% had hyperglycemia compared to 1.6% of younger children (p |
| doi_str_mv | 10.3329/bjch.v45i3.62891 |
| format | Article |
| fullrecord | <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_3329_bjch_v45i3_62891</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_3329_bjch_v45i3_62891</sourcerecordid><originalsourceid>FETCH-crossref_primary_10_3329_bjch_v45i3_628913</originalsourceid><addsrcrecordid>eNqdz8FOhDAYBODGaCLRvXv8XwAsFBCOZpWsyZ6M96ZbytJdaPFvUfv2CtkncC5zmTl8hDykNGEsqx8PJ9knX3mhWVJmVZ1ekSjLaRVXLC2uSUSz4ilmeU1vyca5E_0Lq8usTCPy06D6nJWRAYRp4V27MzRCeosOOouwC5PC4xCkGrUAbWDb66FFZeBb-x6e5ewV7MM49fYwCOe1hL2az-v6ZUZtjvBm2ll6bZevGq3vFYop3JObTgxObS59R2jz-rHdxRKtc6g6PqEeBQaeUr4g-YLkK5KvSPaPyy8Xsl64</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Frequency and Risk Factors for Hyperglycemia in Children with Acute Lymphoblastic Leukemia During Induction Chemotherapy</title><source>Free E-Journal (出版社公開部分のみ）</source><source>Bangladesh Journals Online</source><creator>Ahammed, Md Tanvir</creator><creatorcontrib>Ahammed, Md Tanvir</creatorcontrib><description>Background: Hyperglycemia is a common side effect and it has long been recognized as a consequence of corticosteroids and L-asparaginase, chemotherapeutic agents key to ALL treatment. This study was done to determine the frequency and identify the risk factors for hyperglycemia in paediatric ALL during induction chemotherapy.
Material & Methods: This prospective observational study was done among 87 newly diagnosed ALL cases of 1-18 years of age. After initial work up patient got induction chemotherapy according to UK ALL 2003 (modified) protocol in BSMMU. Anthropometric measurements and CBC, RBS/ 2 hours after glucose/ FBS and corresponding urine sugar was assessed after 2nd, 4th, 6th and 9th dose of Lasparaginase and after completion of induction. Data were analyzed by SPSS 17.0.
Results: Eight patients (9.75%) of the study cohort developed hyperglycemia. Among ³10 years of age 36.8% had hyperglycemia compared to 1.6% of younger children (p<0.001). No gender difference was found. Obese and overweight (p <0.001 in both cases), positive family history of diabetes mellitus using 4 drugs during induction remission phase of chemotherapy were found significant risk factors for hyperglycemia.
Conclusion: In this study frequency of hyperglycemia was 9.75% and frequency of transient hyperglycemia (TH) was 7.3%. Older age, obese or overweight children, positive family history of diabetes mellitus, patient getting regimen B according to UK-ALL 2003 (modified) protocol had shown increase the risk of hyperglycemia.
BANGLADESH J CHILD HEALTH 2021; VOL 45 (3) : 155-161</description><identifier>ISSN: 0257-3490</identifier><identifier>EISSN: 2408-8315</identifier><identifier>DOI: 10.3329/bjch.v45i3.62891</identifier><language>eng</language><ispartof>Bangladesh journal of child health, 2022-11, Vol.45 (3), p.155-161</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4125,27924,27925</link.rule.ids></links><search><creatorcontrib>Ahammed, Md Tanvir</creatorcontrib><title>Frequency and Risk Factors for Hyperglycemia in Children with Acute Lymphoblastic Leukemia During Induction Chemotherapy</title><title>Bangladesh journal of child health</title><description>Background: Hyperglycemia is a common side effect and it has long been recognized as a consequence of corticosteroids and L-asparaginase, chemotherapeutic agents key to ALL treatment. This study was done to determine the frequency and identify the risk factors for hyperglycemia in paediatric ALL during induction chemotherapy.
Material & Methods: This prospective observational study was done among 87 newly diagnosed ALL cases of 1-18 years of age. After initial work up patient got induction chemotherapy according to UK ALL 2003 (modified) protocol in BSMMU. Anthropometric measurements and CBC, RBS/ 2 hours after glucose/ FBS and corresponding urine sugar was assessed after 2nd, 4th, 6th and 9th dose of Lasparaginase and after completion of induction. Data were analyzed by SPSS 17.0.
Results: Eight patients (9.75%) of the study cohort developed hyperglycemia. Among ³10 years of age 36.8% had hyperglycemia compared to 1.6% of younger children (p<0.001). No gender difference was found. Obese and overweight (p <0.001 in both cases), positive family history of diabetes mellitus using 4 drugs during induction remission phase of chemotherapy were found significant risk factors for hyperglycemia.
Conclusion: In this study frequency of hyperglycemia was 9.75% and frequency of transient hyperglycemia (TH) was 7.3%. Older age, obese or overweight children, positive family history of diabetes mellitus, patient getting regimen B according to UK-ALL 2003 (modified) protocol had shown increase the risk of hyperglycemia.
BANGLADESH J CHILD HEALTH 2021; VOL 45 (3) : 155-161</description><issn>0257-3490</issn><issn>2408-8315</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNqdz8FOhDAYBODGaCLRvXv8XwAsFBCOZpWsyZ6M96ZbytJdaPFvUfv2CtkncC5zmTl8hDykNGEsqx8PJ9knX3mhWVJmVZ1ekSjLaRVXLC2uSUSz4ilmeU1vyca5E_0Lq8usTCPy06D6nJWRAYRp4V27MzRCeosOOouwC5PC4xCkGrUAbWDb66FFZeBb-x6e5ewV7MM49fYwCOe1hL2az-v6ZUZtjvBm2ll6bZevGq3vFYop3JObTgxObS59R2jz-rHdxRKtc6g6PqEeBQaeUr4g-YLkK5KvSPaPyy8Xsl64</recordid><startdate>20221120</startdate><enddate>20221120</enddate><creator>Ahammed, Md Tanvir</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20221120</creationdate><title>Frequency and Risk Factors for Hyperglycemia in Children with Acute Lymphoblastic Leukemia During Induction Chemotherapy</title><author>Ahammed, Md Tanvir</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-crossref_primary_10_3329_bjch_v45i3_628913</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Ahammed, Md Tanvir</creatorcontrib><collection>CrossRef</collection><jtitle>Bangladesh journal of child health</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ahammed, Md Tanvir</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Frequency and Risk Factors for Hyperglycemia in Children with Acute Lymphoblastic Leukemia During Induction Chemotherapy</atitle><jtitle>Bangladesh journal of child health</jtitle><date>2022-11-20</date><risdate>2022</risdate><volume>45</volume><issue>3</issue><spage>155</spage><epage>161</epage><pages>155-161</pages><issn>0257-3490</issn><eissn>2408-8315</eissn><abstract>Background: Hyperglycemia is a common side effect and it has long been recognized as a consequence of corticosteroids and L-asparaginase, chemotherapeutic agents key to ALL treatment. This study was done to determine the frequency and identify the risk factors for hyperglycemia in paediatric ALL during induction chemotherapy.
Material & Methods: This prospective observational study was done among 87 newly diagnosed ALL cases of 1-18 years of age. After initial work up patient got induction chemotherapy according to UK ALL 2003 (modified) protocol in BSMMU. Anthropometric measurements and CBC, RBS/ 2 hours after glucose/ FBS and corresponding urine sugar was assessed after 2nd, 4th, 6th and 9th dose of Lasparaginase and after completion of induction. Data were analyzed by SPSS 17.0.
Results: Eight patients (9.75%) of the study cohort developed hyperglycemia. Among ³10 years of age 36.8% had hyperglycemia compared to 1.6% of younger children (p<0.001). No gender difference was found. Obese and overweight (p <0.001 in both cases), positive family history of diabetes mellitus using 4 drugs during induction remission phase of chemotherapy were found significant risk factors for hyperglycemia.
Conclusion: In this study frequency of hyperglycemia was 9.75% and frequency of transient hyperglycemia (TH) was 7.3%. Older age, obese or overweight children, positive family history of diabetes mellitus, patient getting regimen B according to UK-ALL 2003 (modified) protocol had shown increase the risk of hyperglycemia.
BANGLADESH J CHILD HEALTH 2021; VOL 45 (3) : 155-161</abstract><doi>10.3329/bjch.v45i3.62891</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0257-3490 |
| ispartof | Bangladesh journal of child health, 2022-11, Vol.45 (3), p.155-161 |
| issn | 0257-3490 2408-8315 |
| language | eng |
| recordid | cdi_crossref_primary_10_3329_bjch_v45i3_62891 |
| source | Free E-Journal (出版社公開部分のみ）; Bangladesh Journals Online |
| title | Frequency and Risk Factors for Hyperglycemia in Children with Acute Lymphoblastic Leukemia During Induction Chemotherapy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T07%3A38%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Frequency%20and%20Risk%20Factors%20for%20Hyperglycemia%20in%20Children%20with%20Acute%20Lymphoblastic%20Leukemia%20During%20Induction%20Chemotherapy&rft.jtitle=Bangladesh%20journal%20of%20child%20health&rft.au=Ahammed,%20Md%20Tanvir&rft.date=2022-11-20&rft.volume=45&rft.issue=3&rft.spage=155&rft.epage=161&rft.pages=155-161&rft.issn=0257-3490&rft.eissn=2408-8315&rft_id=info:doi/10.3329/bjch.v45i3.62891&rft_dat=%3Ccrossref%3E10_3329_bjch_v45i3_62891%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |